Patient Safety Organizations: Voluntary Delisting, 75471-75472 [2010-30263]

Download as PDF mstockstill on DSKH9S0YB1PROD with NOTICES Federal Register / Vol. 75, No. 232 / Friday, December 3, 2010 / Notices discussed in the Federal Register Notice and background paper that accompanied the public posting of the initial, recommended core set (http:// www.ahrq.gov/chip/ chipraact.htm#Core), not all CHIPRA criteria were able to be met for the initial core set. Public comments on the initial, recommended core set, and an expert meeting on measure criteria for the CHIPRA PQMP (http:// www.AHRQ.gov/chipra/#Expert) provided additional insights into potential priorities for the PQMP. The combination of these efforts and events led to the identification of the following potential priorities for measure enhancement and development of new measures: 1. Development or enhancement of methods to: a. Standardize measures across all payers, programs, and providers, public and private, as appropriate, to ensure that comparisons are valid. b. Assess disparities in quality by race, ethnicity, socioeconomic status, geographic region and residence, and special health care needs, for example by developing new measurement methods or enhancing existing measurement methods. c. Adjust for risk by enrollment duration. d. Stratify or adjust for risk by depth and breadth of coverage. e. Stratify or adjust for risk by medical conditions, including severity and acuity. f. Capitalize on current and coming investments in health information technology (e.g., patient and procedure registries, electronic health records, health information exchanges, interoperability), including meaningful use criteria under the American Recovery and Reinvestment Act (ARRA). g. Increase State programs’ and CMS’s ability to rely on non-Medicaid and CHIP data sources through improvement in public health sector measurement (e.g., birth certificate data; immunization surveys). h. Come to consensus on the meaning and application of ‘‘evidence-based’’ in the context of healthcare quality measurement for children. i. Incorporate patient and family perspectives into measurement to increase understandability. 2. Development or enhancement of measures in key topic areas: a. Most integrated healthcare settings. b. Availability of services. c. Duration of enrollment as a standalone measure. d. Measures of the content (quality) of care now typically measured as broad VerDate Mar<15>2010 16:09 Dec 02, 2010 Jkt 223001 utilization categories (e.g., prenatal, postpartum, newborn care (including breastfeeding support), well-child and adolescent well-care visits, screening services, and follow-up visits for chronic conditions and related medications). e. Specific care settings and conditions: i. Perinatal care (e.g., family planning clinics, obstetric and gynecological care, birth centers). ii. Quality of mental/behavioral health and substance abuse services, including prevention and treatment services, across all settings. iii. Quality of care in settings beyond traditional medical care settings (e.g., for screening, diagnostic services and therapies). iv. Inpatient settings (including specialty inpatient settings). v. Specialty care for child conditions and diseases. vi. Care transitions for patients transitioning within and across health care settings. vii. Additional measures related to family experiences of care (e.g., child or adolescent self-reports; perinatal experiences of care; inpatient experiences) viii. Health outcome measures (e.g., measures of patient and population health or other outcomes of healthcare).2 ix. Structural measures (e.g., measures of system design features that are causally linked to improved healthcare processes and outcomes). Those submitting comments are encouraged to include a summary of evidence for the readiness of a topic for quality measurement and the importance of a topic or method. Additional background information may be attached. Commenters may wish to address these issues using the following questions. Commenters may also wish to include in their comments a summary score based on a scale of 1–5, where 1 is a high score, 3 is a medium score, and 5 is a low score. Validity/Underlying Scientific Soundness: To what extent is there a demonstrated causal relationship between the element of quality to be measured (as a structure, process, or health outcome of healthcare delivery) and another element of the healthcare delivery system (e.g., structure and process; process and outcome). Commenters may wish to use as a guide to assessing underlying scientific soundness the method and criteria used by the AHRQ National Advisory Council Subcommittee on Children’s Healthcare Quality Measures for Medicaid and CHIP, where appropriate PO 00000 Frm 00021 Fmt 4703 Sfmt 4703 75471 http://www.AHRQ.gov/chipra/ corebackground/ corebacktab.htm#note5). Importance: Importance has several dimensions: • To what extent is the topic important to children’s health outcomes, family functioning, or societal functioning, including but not necessarily limited to high monetary costs of poor quality healthcare to children, families, or Society? • To what extent is the topic important to reducing disparities in the quality of care for particular racial and ethnic groups of children, socioeconomic groups, geographically underserved groups, and children with special healthcare needs? • To what extent is the topic important as a sentinel measure that could have spillover effects to the rest of the children’s healthcare delivery system? • To what extent is the proposed methodology important for addressing current shortcoming of healthcare quality measurement? We strongly encourage comments to be as succinct as possible (250 words or less per topic, with additional supporting data allowed). 3. Collection of Information Requirements This voluntary request does not impose information collection and recordkeeping requirements. Consequently, it need not be reviewed by the Office of Management and Budget under the authority of the Paperwork Reduction Act of 1995 (44 U.S.C. 35). 4. Regulatory Impact Analysis As this notice does not meet the significance criteria of Executive Order 12866, it was not reviewed by the Office of Management and Budget. Dated: November 24, 2010. Carolyn M. Clancy, AHRQ Director. [FR Doc. 2010–30262 Filed 12–2–10; 8:45 am] BILLING CODE 4160–90–M DEPARTMENT OF HEALTH AND HUMAN SERVICES Agency for Healthcare Research and Quality Patient Safety Organizations: Voluntary Delisting Agency for Healthcare Research and Quality, HHS. ACTION: Notice of Delisting. AGENCY: E:\FR\FM\03DEN1.SGM 03DEN1 75472 Federal Register / Vol. 75, No. 232 / Friday, December 3, 2010 / Notices AHRQ has accepted a notification of voluntary relinquishment from ORQA, LLC of its status as a Patient Safety Organization (PSO). The Patient Safety and Quality Improvement Act of 2005 (Patient Safety Act), Public Law 109–41, 42 U.S.C. 299b–21—b–26, provides for the formation of PSOs, which collect, aggregate, and analyze confidential information regarding the quality and safety of health care delivery. The Patient Safety and Quality Improvement Final Rule (Patient Safety Rule), 42 CFR Part 3, authorizes AHRQ, on behalf of the Secretary of HHS, to list as a PSO an entity that attests that it meets the statutory and regulatory requirements for listing. A PSO can be ‘‘delisted’’ by the Secretary if it is found to no longer meet the requirements of the Patient Safety Act and Patient Safety Rule, including when a PSO chooses to voluntarily relinquish its status as a PSO for any reason. DATES: The directories for both listed and delisted PSOs are ongoing and reviewed weekly by AHRQ. The delisting was effective at 12 Midnight ET (2400) on October 13, 2010. ADDRESSES: Both directories can be accessed electronically at the following HHS Web site: http:// www.pso.AHRQ.gov/index.html. FOR FURTHER INFORMATION CONTACT: Diane Cousins, RPh., Center for Quality Improvement and Patient Safety, AHRQ, 540 Gaither Road, Rockville, MD 20850; Telephone (toll free): (866) 403–3697; Telephone (local): (301) 427–1111; TTY (toll free): (866) 438–7231; TTY (local): (301) 427–1130; E-mail: pso@AHRQ.hhs.gov. SUPPLEMENTARY INFORMATION: mstockstill on DSKH9S0YB1PROD with NOTICES SUMMARY: Background The Patient Safety Act authorizes the listing of PSOs, which are entities or component organizations whose mission and primary activity is to conduct activities to improve patient safety and the quality of health care delivery. HHS issued the Patient Safety Rule to implement the Patient Safety Act. AHRQ administers the provisions of the Patient Safety Act and Patient Safety Rule (PDF file, 450 KB. PDF Help) relating to the listing and operation of PSOs. Section 3.108(d) of the Patient Safety Rule requires AHRQ to provide public notice when it removes an organization from the list of federally approved PSOs. AHRQ has accepted a notification from ORQA, LLC, PSO number P0013, to voluntarily relinquish its status as a PSO. Accordingly, ORQA, LLC was delisted effective at 12 Midnight ET (2400) on October 13, 2010. VerDate Mar<15>2010 16:09 Dec 02, 2010 Jkt 223001 More information on PSOs can be obtained through AHRQ’s PSO Web site at http://www.pso.AHRQ.gov/ index.html. Dated: November 24, 2010. Carolyn M. Clancy, Director. [FR Doc. 2010–30263 Filed 12–2–10; 8:45 am] BILLING CODE 4160–90–M DEPARTMENT OF HEALTH AND HUMAN SERVICES Agency for Healthcare Research and Quality Patient Safety Organizations: Voluntary Delisting Agency for Healthcare Research and Quality, HHS. ACTION: Notice of Delisting. AGENCY: AHRQ has accepted a notification of voluntary relinquishment from Helmet Fire, Inc. Patient Safety Group (A Component of Helmet Fire, Inc. of its status as a Patient Safety Organization (PSO). The Patient Safety and Quality Improvement Act of 2005 (Patient Safety Act), Public Law 109–41, 42 U.S.C. 299b–21—b–26, provides for the formation of PSOs, which collect, aggregate, and analyze confidential information regarding the quality and safety of health care delivery. The Patient Safety and Quality Improvement Final Rule (Patient Safety Rule), 42 CFR Part 3, authorizes AHRQ, on behalf of the Secretary of HHS, to list as a PSO an entity that attests that it meets the statutory and regulatory requirements for listing. A PSO can be ‘‘delisted’’ by the Secretary if it is found to no longer meet the requirements of the Patient Safety Act and Patient Safety Rule, including when a PSO chooses to voluntarily relinquish its status as a PSO for any reason. DATES: The directories for both listed and delisted PSOs are ongoing and reviewed weekly by AHRQ. The delisting was effective at 12 Midnight ET (2400) on October 13, 2010. ADDRESSES: Both directories can be accessed electronically at the following HHS Web site: http:// www.pso.AHRQ.gov/index.html. FOR FURTHER INFORMATION CONTACT: Diane Cousins, RPh., Center for Quality Improvement and Patient Safety, AHRQ, 540 Gaither Road, Rockville, MD 20850; Telephone (toll free): (866) 403–3697; Telephone (local): (301) 427–1111; TTY (toll free): (866) 438–7231; TTY (local): (301) 427–1130; E-mail: pso@AHRQ.hhs.gov. SUMMARY: PO 00000 Frm 00022 Fmt 4703 Sfmt 4703 SUPPLEMENTARY INFORMATION: Background The Patient Safety Act authorizes the listing of PSOs, which are entities or component organizations whose mission and primary activity is to conduct activities to improve patient safety and the quality of health care delivery. HHS issued the Patient Safety Rule to implement the Patient Safety Act. AHRQ administers the provisions of the Patient Safety Act and Patient Safety Rule (PDF file, 450 KB. PDF Help) relating to the listing and operation of PSOs. Section 3.108(d) of the Patient Safety Rule requires AHRQ to provide public notice when it removes an organization from the list of federally approved PSOs. AHRQ has accepted a notification from Helmet Fire, Inc. Patient Safety Group (A Component of Helmet Fire, Inc., PSO number P0023, to voluntarily relinquish its status as a PSO. Accordingly, Helmet Fire, Inc. Patient Safety Group (A Component of Helmet Fire, Inc) was delisted effective at 12 Midnight ET (2400) on October 13, 2010. More information on PSOs can be obtained through AHRQ’s PSO Web site at http://www.pso.AHRQ.gov/ index.html. Dated: November 24, 2010. Carolyn M. Clancy, Director. [FR Doc. 2010–30267 Filed 12–2–10; 8:45 am] BILLING CODE 4160–90–M DEPARTMENT OF HEALTH AND HUMAN SERVICES Agency for Healthcare Research and Quality Patient Safety Organizations: Voluntary Delisting Agency for Healthcare Research and Quality (AHRQ), HHS. ACTION: Notice of Delisting. AGENCY: AHRQ has accepted a notification of voluntary relinquishment from Human Performance Technology Group, Inc. of its status as a Patient Safety Organization (PSO). The Patient Safety and Quality Improvement Act of 2005 (Patient Safety Act), Public Law 109–41, 42 U.S.C. 299b–21—b–26, provides for the formation of PSOs, which collect, aggregate, and analyze confidential information regarding the quality and safety of health care delivery. The Patient Safety and Quality Improvement Final Rule (Patient Safety Rule), 42 CFR Part 3, authorizes AHRQ, SUMMARY: E:\FR\FM\03DEN1.SGM 03DEN1

Agencies

[Federal Register Volume 75, Number 232 (Friday, December 3, 2010)]
[Notices]
[Pages 75471-75472]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-30263]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Agency for Healthcare Research and Quality


Patient Safety Organizations: Voluntary Delisting

AGENCY: Agency for Healthcare Research and Quality, HHS.

ACTION: Notice of Delisting.

-----------------------------------------------------------------------

[[Page 75472]]

SUMMARY: AHRQ has accepted a notification of voluntary relinquishment 
from ORQA, LLC of its status as a Patient Safety Organization (PSO). 
The Patient Safety and Quality Improvement Act of 2005 (Patient Safety 
Act), Public Law 109-41, 42 U.S.C. 299b-21--b-26, provides for the 
formation of PSOs, which collect, aggregate, and analyze confidential 
information regarding the quality and safety of health care delivery. 
The Patient Safety and Quality Improvement Final Rule (Patient Safety 
Rule), 42 CFR Part 3, authorizes AHRQ, on behalf of the Secretary of 
HHS, to list as a PSO an entity that attests that it meets the 
statutory and regulatory requirements for listing. A PSO can be 
``delisted'' by the Secretary if it is found to no longer meet the 
requirements of the Patient Safety Act and Patient Safety Rule, 
including when a PSO chooses to voluntarily relinquish its status as a 
PSO for any reason.

DATES: The directories for both listed and delisted PSOs are ongoing 
and reviewed weekly by AHRQ. The delisting was effective at 12 Midnight 
ET (2400) on October 13, 2010.

ADDRESSES: Both directories can be accessed electronically at the 
following HHS Web site: http://www.pso.AHRQ.gov/index.html.

FOR FURTHER INFORMATION CONTACT: Diane Cousins, RPh., Center for 
Quality Improvement and Patient Safety, AHRQ, 540 Gaither Road, 
Rockville, MD 20850; Telephone (toll free): (866) 403-3697; Telephone 
(local): (301) 427-1111; TTY (toll free): (866) 438-7231; TTY (local): 
(301) 427-1130; E-mail: pso@AHRQ.hhs.gov.

SUPPLEMENTARY INFORMATION:

Background

    The Patient Safety Act authorizes the listing of PSOs, which are 
entities or component organizations whose mission and primary activity 
is to conduct activities to improve patient safety and the quality of 
health care delivery. HHS issued the Patient Safety Rule to implement 
the Patient Safety Act. AHRQ administers the provisions of the Patient 
Safety Act and Patient Safety Rule (PDF file, 450 KB. PDF Help) 
relating to the listing and operation of PSOs. Section 3.108(d) of the 
Patient Safety Rule requires AHRQ to provide public notice when it 
removes an organization from the list of federally approved PSOs. AHRQ 
has accepted a notification from ORQA, LLC, PSO number P0013, to 
voluntarily relinquish its status as a PSO. Accordingly, ORQA, LLC was 
delisted effective at 12 Midnight ET (2400) on October 13, 2010.
    More information on PSOs can be obtained through AHRQ's PSO Web 
site at http://www.pso.AHRQ.gov/index.html.

    Dated: November 24, 2010.
Carolyn M. Clancy,
Director.
[FR Doc. 2010-30263 Filed 12-2-10; 8:45 am]
BILLING CODE 4160-90-M